To further test how PD-1 expression in peripheral blood affects clinical characteristics based on the expression of PD-1+ on CD8+T cells, we studied clinical characteristics such as age, tumor staging, histological types, tumor differentiation, lymph node metastasis, tumor diameter, invasion depth, and tumor metastasis. This evidence concerns the gene CD8A and neoplasm.